Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit Life Science Investing
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference Life Science Investing
Quarterly Activities Report: Melodiol Delivers $9.3m in Revenue During H1 FY24 – a 33% Increase the PCP SmartNews
$12M Proposed Cash Asset Sale to Strengthen Balance Sheet, with $2.2M of Earn Outs Psychedelics Investing
